About DeepEcho
DeepEcho is an AI medical imaging company dedicated to revolutionizing prenatal care and combating preventable maternal and neonatal deaths globally. Their core offering is an AI-powered software that integrates with real-time ultrasound video, guiding users through standardized probe sweeps and automatically generating crucial measurements and diagnostic insights. This technology is designed to mimic the expertise of a trained sonographer, thereby significantly enhancing the efficiency and accuracy of fetal ultrasound diagnostics while reducing both the time and cost of care.
For physicians, DeepEcho’s platform provides advanced tools for early and precise detection of high-risk pregnancy conditions such as fetal growth restriction (FGR), anatomical anomalies, and preeclampsia. The system leverages deep learning to automate the identification of fetal ultrasound views, standardize image acquisition, and analyze fetal biometry and amniotic fluid volume, ensuring consistent and reproducible results. This capability is particularly impactful in bridging gaps in medical expertise and infrastructure, enabling both radiologists and minimally trained clinicians to perform accurate fetal assessments. DeepEcho has also achieved FDA 510(k) clearance for its fetal ultrasound analysis platform, underscoring the rigor and safety of its technology.
Focus Areas
Business Intelligence
| Key Investors | Algebra Ventures, Al Mada Ventures, UM6P Ventures, Plug and Play, AAIC Investment, Catalytic Impact Foundation, Google Accelerator, Cure Experience Services, African Union Development Agency-NEPAD, Bill and Melinda Gates Foundation (grant), Microsoft, Nvidia, Orange, European Bank |
| Partnerships | Ministry of Health (Morocco), Butterfly Network (Butterfly Garden), GUSI, Microsoft (Azure Healthcare platform), leading ultrasound manufacturers |
| Technology | AI-powered software, deep learning algorithms, computer vision, hardware-agnostic, mobile app with offline capabilities, real-time ultrasound video analysis, advanced segmentation of structures |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, DeepEcho offers a powerful tool to enhance diagnostic confidence and streamline workflows. The AI-driven insights can help in early identification of potential complications, allowing for proactive management and personalized care plans. The system's ability to provide consistent, objective measurements can reduce inter-operator variability and improve the overall quality of prenatal assessments. Utilize the predictive analytics to better stratify patient risk and prioritize interventions, ultimately leading to improved patient outcomes and more efficient clinic operations.
DeepEcho's platform is designed for seamless integration with existing PACS (Picture Archiving and Communication Systems) and EMR/EHR (Electronic Medical Record/Electronic Health Record) systems. This ensures that AI-generated reports and imaging data can be easily incorporated into a physician's current workflow, minimizing disruption and maximizing utility. API availability for custom integrations is also a key feature, allowing for flexible deployment in diverse clinical environments.
What the Web Says
DeepEcho is an AI-first healthtech company founded in 2020, focused on revolutionizing prenatal care through AI-powered fetal ultrasound diagnostics. The company's platform automates fetal ultrasound imaging by recognizing standard fetal views, segmenting anatomical structures, and computing biometric measurements, aiming to reduce operator variability and streamline workflow. DeepEcho has received recognition as one of TIME and Statista's World's Top HealthTech Companies of 2025 and has secured FDA 510(k) clearance for its fetal ultrasound analysis platform. Their technology has been shown to perform with consistency matching or exceeding human sonographers.
Overall: PositiveStrengths
- Automates fetal ultrasound imaging, recognizing standard views and computing biometric measurements.
- Reduces operator variability and streamlines workflow in prenatal care.
- Achieved FDA 510(k) clearance for its fetal ultrasound analysis platform.
- Clinical studies show models performing with consistency matching or exceeding human sonographers.
- Aims to democratize access to quality ultrasound, especially in underserved areas, and improve efficiency in developed countries.
- Developing next-generation AI tools for earlier prediction of complex conditions like preeclampsia.
Limitations
- No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit for 'DeepEcho' as a healthtech company. The search results for these platforms yielded reviews for other companies with 'Echo' in their name or general AI tools.
- Claims, figures, and metrics on their website are stated to be from their own clinical studies and/or scientific papers, and are currently under scientific & regulatory review, and not yet validated by the FDA (though FDA 510(k) clearance has been achieved for the platform).
Based on reviews from: TIME & Statista, Femtech Insider, DeepEcho Website, Newswire, Butterfly Garden
Last updated: 2026-07-18
Videos
News, demos, and interviews about DeepEcho.
Videos load interactively. If none appear, search YouTube for DeepEcho →
Press & Coverage
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]